{"name":"Hugel","slug":"hugel","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Botulinum Toxin Type A Injection [Botox]","genericName":"Botulinum Toxin Type A Injection [Botox]","slug":"botulinum-toxin-type-a-injection-botox","indication":"Other","status":"marketed"},{"name":"Botulinum toxin type A injection [HG-102]","genericName":"Botulinum toxin type A injection [HG-102]","slug":"botulinum-toxin-type-a-injection-hg-102","indication":"Other","status":"phase_1"},{"name":"Hugeltox","genericName":"Hugeltox","slug":"hugeltox","indication":"Other","status":"phase_3"},{"name":"LETYBO","genericName":"LETIBOTULINUMTOXINA-WLBG","slug":"letibotulinumtoxina-wlbg","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Botulinum Toxin Type A Injection [HG102]","genericName":"Botulinum Toxin Type A Injection [HG102]","slug":"botulinum-toxin-type-a-injection-hg102","indication":"Cervical dystonia","status":"phase_3"},{"name":"Botulinum toxin type A injection","genericName":"Botulinum toxin type A injection","slug":"botulinum-toxin-type-a-injection","indication":"Cervical dystonia","status":"marketed"}]}],"pipeline":[{"name":"Botulinum Toxin Type A Injection [Botox]","genericName":"Botulinum Toxin Type A Injection [Botox]","slug":"botulinum-toxin-type-a-injection-botox","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Botulinum Toxin Type A Injection [HG102]","genericName":"Botulinum Toxin Type A Injection [HG102]","slug":"botulinum-toxin-type-a-injection-hg102","phase":"phase_3","mechanism":"Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","indications":["Cervical dystonia","Blepharospasm","Hemifacial spasm","Chronic migraine","Spasticity"],"catalyst":""},{"name":"Botulinum toxin type A injection","genericName":"Botulinum toxin type A injection","slug":"botulinum-toxin-type-a-injection","phase":"marketed","mechanism":"Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","indications":["Cervical dystonia","Blepharospasm","Hemifacial spasm","Glabellar lines (aesthetic)","Crow's feet (aesthetic)"],"catalyst":""},{"name":"Botulinum toxin type A injection [HG-102]","genericName":"Botulinum toxin type A injection [HG-102]","slug":"botulinum-toxin-type-a-injection-hg-102","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hugeltox","genericName":"Hugeltox","slug":"hugeltox","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LETYBO","genericName":"LETIBOTULINUMTOXINA-WLBG","slug":"letibotulinumtoxina-wlbg","phase":"marketed","mechanism":"","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPNHlYekVIcWNXbTAzekpSQ1pUYkgyS1RYVzdCWEVCLUM4QlhJYjhlYmFoOEZ2RGFVTmxiZmZ5dW9CMHg0cFQxSWEwSXF6YzVhNlRkNTlPOUNpQlo2SjlXRWlvRzVBVGdETFg3VkgtMjI3V1F1RFBmbU5PNlpBVmF0WjRncHZwTmpNT09FdHFjSkc0aTdqUFJjbGpKUEdLOUROellVcVpmaFNKZUY4MF9MVE1xYUd3QTUxMkJCRlBaZUxLcXZ1VGx2TU4tTm4yNlNwaHlzUThtd0p0QlR1R1ZTMldUSHFaSnZVYlFxYWZvaUQwZFZiLVAxemFIc3FUUQ?oc=5","date":"2026-01-16","type":"pipeline","source":"Korea JoongAng Daily","summary":"Korea's Hugel to launch direct sales in bid to expand share in U.S. medical aesthetics market - Korea JoongAng Daily","headline":"Korea's Hugel to launch direct sales in bid to expand share in U.S. medical aesthetics market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1TckVDUWRJeU01ZG9kTVBvUVdPQmE3NE1MdGJwTHctdThRN3A2LXN6Nk1fOWlBZGZzeGcwVEFBQzF2V2JjNlhEWkNQbHd0dU5iWHdWVWxkSE1lQ2tWdjBFMWQyR01YV3ZEM1FGd2VR?oc=5","date":"2025-11-03","type":"pipeline","source":"KED Global","summary":"Korean botox exports hit record high; growth faster than semiconductors - KED Global","headline":"Korean botox exports hit record high; growth faster than semiconductors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE10VUVCdnFDeksyQk03SHM2alZyZ2VneUUtVmpxWDdoRlZJekVCWF9Pa0JVTlkzc1FObWVkT1lYVkxJSFhtYkRRMjNhSDM2UlZxOTF4bWJTTzVXWWRfNkVIdXRPSlkwSmI2OVJKMzJ30gFyQVVfeXFMT0d2RTNFbThPN0trU2oyQnBOZWItbnNXZV9jdnZ2TUVsRE8tNl9lbEtUaGpXZVIydTlPMURzMTk1c1FkQmRIdGxTYzVueVpQNzYtdTlFZ3ktUlJ0VlVBd011ZTgybXhyRDRZNTBEQ3ZrZjln?oc=5","date":"2025-10-14","type":"pipeline","source":"koreabiomed.com","summary":"Hugel names ex-Allergan Aesthetics chief Carrie Strom as global CEO - koreabiomed.com","headline":"Hugel names ex-Allergan Aesthetics chief Carrie Strom as global CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQdEhwOGRuZ3ZPelU2aW9zaHhzdjVVd1RPamo3RFlzd0VxbTAyMVZkNTlCSnVLUWFNTEFBX2hodmZaZnRlWFVma2gzZUlHYzVzQWZNcHpaWTFGYnE2Qm9pa044NUdPaUdXSDdjbUl4OFprSHo5d3Q5eWNlNktyVzluRHdaTnVkQjlGUkZ4OFpWcnhySjBvd2lTUG5FeUZncXFPZFRqOFhmME9xWkZWLXBkMEh0Z3o?oc=5","date":"2025-10-13","type":"pipeline","source":"PR Newswire","summary":"Hugel Inc. appoints Carrie Strom as Chief Executive Officer - PR Newswire","headline":"Hugel Inc. appoints Carrie Strom as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1uaTY0bk4ta0d0Wk5URHlvaEd6VFJZdGthVGlwQWxOTUxZMnozZHpQTmJOUzZIVzRoOVNhc1pDOVJEc3Z5Y2xydlVOZ0FJMG9DWExfclVDWUJpUGVZTEZZX3RjR3lsWmVJRDlTSUhn0gFyQVVfeXFMTmItX0NSdE1nMVg5Um5LSEM1Yk13Tl9ieG5ocU1RdnBfVGhiRnU0UElhT2VBR2c2QWJUMXJsRlhkaEc4ZW96UTVpX0tjYXBEV1A1SWg1SWtnUWo0R0N0LTZ6V1JFanBRVVp1TFFuaDJRS3p3?oc=5","date":"2025-05-09","type":"earnings","source":"koreabiomed.com","summary":"Hugel posts record Q1 earnings with balanced product growth, global momentum - koreabiomed.com","headline":"Hugel posts record Q1 earnings with balanced product growth, global momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE13MG51R0hibmtpUDRmLVRYbmg1UzR2ODk2dUcxT1N3QzN5aFk2cGc5Z0l3Wkd1dzFXVXdiSmxTZk5zc28wZHhkQ1Y5T0RqSEkzci0yRU1POFptUnVfclFDQ25WbEwwTTd4QnRSYVV30gFyQVVfeXFMTjM5cXR2UThtVEFLbnBBVEE3TWh2bHZhTURDUjNETzJiVmU5RkN3Mld2OVhTVTRCQktoMi1sS05JSWI1ZkVXb0xxYmNvdnVqXzRfai1wdkNva2hWMzQxb3dBUUZETk5xdDhjaGkwWEZzUl9B?oc=5","date":"2025-03-26","type":"pipeline","source":"koreabiomed.com","summary":"Hugel, BENEV launch Hugel’s botulinum toxin Letybo in US - koreabiomed.com","headline":"Hugel, BENEV launch Hugel’s botulinum toxin Letybo in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBCcEJZVmlNV0s2dUdCbXpZSnJzX2pmdjF1aWVTdHpfOC1jbnVaYS1qOWc5SlJBZU4xQ1FHUjdVLTZqMm1sSU5GaVRhNXEzME10QUNuLV8wU3J2VXZPbTNaSGdGY3dYRnhhZHhER0Vn0gFyQVVfeXFMTTZTNXFDeHBKNEJtamk2NkxGWVZ5VEFicWs4bzlzUVRNYXZBQnN5amRkZTgxOG1mS09GTkhDOFM2WkVkQ1JONld1V0l5SHdWVEhTVmhUU3B0UUkyX2lrNnRiLXVxSHV5RldYbUpiQU1XSVVR?oc=5","date":"2025-03-14","type":"pipeline","source":"koreabiomed.com","summary":"Hugel appoints Park Chul-min as new representative executive officer - koreabiomed.com","headline":"Hugel appoints Park Chul-min as new representative executive officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE0wbW9FREJpenJJSXg2bzNrM1lndXhOMmw0dVQydnY5MXl1LWxDcFQ4NmE4ZlpuNFdnSDVDYmlONk5xMnU2ME1SV3Jhd0RkLXhUSW0wcjJrbmxWZWFMUXBZcEhTWVE2SFVLLTVMZnlR0gFyQVVfeXFMTVRSU1dVSVBreGtrNkRETkt4NU1vNTFTZ1dfelRZdXZGaDFGY1lyOEItMzRybjRaajd0ek8xNzIzMjNIeXlNMFhYMlA4Mm5LVmdqWVdBY3dmak5TTjJsWDAteV83MmkxU1NBZHhPc09PUFRB?oc=5","date":"2024-10-11","type":"pipeline","source":"koreabiomed.com","summary":"Hugel wins ITC dispute against Medytox regarding BTX trade secret, opening doors for US entry - koreabiomed.com","headline":"Hugel wins ITC dispute against Medytox regarding BTX trade secret, opening doors for US entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE95a3BPNEQ4MUZjWmVfTjl3WXRVS0JtUDFkQzBXZVFWai1LNkhtVnQ4blVpczZzNnBGNjMwY0FBS3JiM09HdF9kNmtpRUt6T2p2bVZ2TERUYUdlQldaWjhIaW53MmdzMjNvTEx4SHNR0gFyQVVfeXFMTm16TC1ER3M2T3dpMF9Pbk5KUi1WOS1LQXcxTkE2am42VmI5VFBPOGJCTFRhX2psdy1YbjFJTER2UkZKeGJrQUJPdW5ZLWVQbV9uX29qSWtGMEtOZ1B0WWlYMHdyOU9ESEZYdEtoOGhoWXN3?oc=5","date":"2023-04-18","type":"regulatory","source":"koreabiomed.com","summary":"Hugel hit with another complete response letter from the FDA - koreabiomed.com","headline":"Hugel hit with another complete response letter from the FDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1lbEREMTFxZElOMEJ0WlJBa1hQV29CdFYzZ0c5WmtXZVhrV0c0ajRObXVkaEl1OEV6bzU5aFd0R05lSkNKQ3F0Z0p2T3l3R25qa2JCUTRuZEpYNWNPeG1aZFF0ZnMtVEFTV294dldR?oc=5","date":"2022-04-01","type":"pipeline","source":"KED Global","summary":"Medytox files complaint with ITC against Hugel over botox strain - KED Global","headline":"Medytox files complaint with ITC against Hugel over botox strain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxPLVQ0TW1sa0p1cnF3NnJkTEJyem9EMkhQMDN2SDFPbHdWNGxPZUxJYkNQdW1RVU4ycjZ4LTFGWWVJcmRydW1qX281WFgtcG9sNUd0UFNVd0hDX1pzczZERXMzMVQ3M3FuNUR1VXlEU2wyNDZMQXl5NE5DeDRZbXZCUkdicnA4WENuSmRYbHlmS1JDM3V1SXdiRnBiS2VwNFlZeVBuS2VOSnZUbVBsMk9FczZ1UDN1S0UtUmE3UlJsM2MzQktNLWJ6eWxBTnpTekV1MDVjMk5CcmJibkFWN1ZqSjk0cWxGcFpzR1lvVEV2UWxkM3Q5eUFHMHBIZGQ0TndyVTlmU3JqLTF1MFU1SEhHZ2RfbVdac01lcTdqOHJMclVfaVRYRUoyeWhCQQ?oc=5","date":"2022-01-27","type":"pipeline","source":"Business Wire","summary":"Hugel America, Inc. Announces Successful Completion of Croma-Pharma’s Decentralized Procedure for Letybo - Business Wire","headline":"Hugel America, Inc. Announces Successful Completion of Croma-Pharma’s Decentralized Procedure for Letybo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxNX1Fvd0R0eUZEQV9vMkg5eWpFYllGMV9jN1JLeEktRTM0ZTlBVDI2VGZTWmUtU3Jqc1JCNzRyYXJkWjRQdE5kOW1WRzZOdW5BaFR5Z1FHZHRiZHlLYkNrSmpIb2xhM0hBWWhINGhUTjRKVjhBUDYtbWxGT1BzTG44RmNZX2hWZm8tNURrQ0F0SURwTEp2Q21jQ2tkZi1zaEtXX2NJSTBDRzNvczFXRjFDVHd5S2YxbXZNR1MtWUJpMmQyVG9ZLWRuRUtnU0ZtYWViLUNVV3gtOFp3Y0RYNUVoNmhuaDNNYmJiWUJDeC1xMFRhakplRzdEck1LRXdOeGNaLWtHZU5FSHFGdnRmYkRTT2VRZU9rdHNFYkV4cjB4MWlwUmpKYWk4Sk8wczJaS3Vq?oc=5","date":"2021-06-15","type":"regulatory","source":"PR Newswire","summary":"Hugel America, Inc. Announces U.S. FDA Acceptance of Biologics License Application (BLA) for LetibotulinumtoxinA for Injection to Treat Glabellar (Frown) Lines - PR Newswire","headline":"Hugel America, Inc. Announces U.S. FDA Acceptance of Biologics License Application (BLA) for LetibotulinumtoxinA for Inj","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"marketed":3,"phase_3":2,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}